Pre-order Enquiry
Request Free Sample
Global Contrast Agents Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
SKU ID : GIR-13856649 | Publishing Date : 15-Feb-2019 | No. of pages : 115
Request Sample
Request Customization
Check Discounts
Contrast agents are chemicals, which are used to enhance the image effect to observe by injecting (or taking) into human tissue or organs. The density of contrast agents is higher or lower than surrounding tissue and this contrast can display images via some device.
Contrast agents are widely used in diagnostic imaging procedures such as CT scans, MRIs, X-rays, ultrasounds, and related procedures.
Scope of the Report:
In terms of volume, the production of contrast agents was about 242794 K Dose in 2015 and is anticipated to reach 329523 K Dose by 2021.
The contrast agents industry is a quite concentrated market with a few companies dominates the market. Bayer is the dominate producer of contrast agents, the production was 74476 K Dose in 2015, accounting for about 30.67% of the total amount, followed by GE Healthcare, with the production market share of 25.54 %. The top four companies occupied about 79.40 % production share of the market in 2015.
At present, in the foreign industrial developed countries the contrast agents industry is generally at a more advanced level, the world's large enterprises are mainly concentrated in the North America
Europe and Japan, accounted for most of the international market share. Meanwhile, these companies have more advanced equipment, strong R&D capabilities; the technical level is in a leading position.
The emerging markets (such as China, India) have relatively small scales. However, they have much higher market increasing growth than developed countries. They are the main growth areas in the global contrast agents market.
The sales volume shares of North America, Europe, Japan, China, India and Southeast Asia were 27.91%, 19.65%, 22.52%, 11.07%, 7.35% and 3.52%.
There are mainly two types of contrast agents: iodine preparations type and gadolinium preparations type. Currently, iodine preparations type is the main product and it occupied 81 % share in 2015.
X-CT accounted for the largest market with about 85.10 % market share of the global contrast agents consumption in 2015. Moreover, it is anticipated to grow at a CAGR of 4.92 % from 2016 to 2021. With over 13 % share in the contrast agents market, MRI was the second largest application market in 2015, and is anticipated to grow at a CAGR of 5.71% in terms of consumption volume, from 2016 to 2021.
Under the influence of raw material, market competitions and economic conditions, the price of contrast agents was fluctuant in recent years. Over the next few years, we predict that price will decline. As competition intensifies, prices gap between different brands will go narrowing.
The worldwide market for Contrast Agents is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Contrast Agents in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bayer
GE Healthcare
Bracco Imaging
Guerbet Group
Hengrui Medicine
YRPG
Lantheus
BeiLu Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Iodine Preparations
Gadolinium Preparations
Others
Market Segment by Applications, can be divided into
X-CT
MRI
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Contrast Agents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Contrast Agents, with price, sales, revenue and global market share of Contrast Agents in 2017 and 2018.
Chapter 3, the Contrast Agents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Contrast Agents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Contrast Agents market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Contrast Agents sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Contrast agents are widely used in diagnostic imaging procedures such as CT scans, MRIs, X-rays, ultrasounds, and related procedures.
Scope of the Report:
In terms of volume, the production of contrast agents was about 242794 K Dose in 2015 and is anticipated to reach 329523 K Dose by 2021.
The contrast agents industry is a quite concentrated market with a few companies dominates the market. Bayer is the dominate producer of contrast agents, the production was 74476 K Dose in 2015, accounting for about 30.67% of the total amount, followed by GE Healthcare, with the production market share of 25.54 %. The top four companies occupied about 79.40 % production share of the market in 2015.
At present, in the foreign industrial developed countries the contrast agents industry is generally at a more advanced level, the world's large enterprises are mainly concentrated in the North America
Europe and Japan, accounted for most of the international market share. Meanwhile, these companies have more advanced equipment, strong R&D capabilities; the technical level is in a leading position.
The emerging markets (such as China, India) have relatively small scales. However, they have much higher market increasing growth than developed countries. They are the main growth areas in the global contrast agents market.
The sales volume shares of North America, Europe, Japan, China, India and Southeast Asia were 27.91%, 19.65%, 22.52%, 11.07%, 7.35% and 3.52%.
There are mainly two types of contrast agents: iodine preparations type and gadolinium preparations type. Currently, iodine preparations type is the main product and it occupied 81 % share in 2015.
X-CT accounted for the largest market with about 85.10 % market share of the global contrast agents consumption in 2015. Moreover, it is anticipated to grow at a CAGR of 4.92 % from 2016 to 2021. With over 13 % share in the contrast agents market, MRI was the second largest application market in 2015, and is anticipated to grow at a CAGR of 5.71% in terms of consumption volume, from 2016 to 2021.
Under the influence of raw material, market competitions and economic conditions, the price of contrast agents was fluctuant in recent years. Over the next few years, we predict that price will decline. As competition intensifies, prices gap between different brands will go narrowing.
The worldwide market for Contrast Agents is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Contrast Agents in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bayer
GE Healthcare
Bracco Imaging
Guerbet Group
Hengrui Medicine
YRPG
Lantheus
BeiLu Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Iodine Preparations
Gadolinium Preparations
Others
Market Segment by Applications, can be divided into
X-CT
MRI
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Contrast Agents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Contrast Agents, with price, sales, revenue and global market share of Contrast Agents in 2017 and 2018.
Chapter 3, the Contrast Agents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Contrast Agents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Contrast Agents market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Contrast Agents sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
